Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: a population-based cohort study
Juurlink DN, Gomes T, Lipscombe LL, Austin PC, Hux JE, Mamdani MM. BMJ. 2009; 339:b2942.
Juurlink DN, Gomes T, Lipscombe LL, Austin PC, Hux JE, Mamdani MM. BMJ. 2009; 339:b2942.
Kulkarni GS, Urbach DR, Austin PC, Fleshner NE, Laupacis A. J Urol. 2009; 182(4):1318-24. Epub 2009 Aug 14.
Austin PC. Med Decis Making. 2009; 29(6):661-7. Epub 2009 Aug 14.
Kavsak PA, Wang X, Ko DT, MacRae AR, Jaffe AS. Clin Chem. 2009; 55(10):1809-15. Epub 2009 Aug 13.
Puterman J, Alter DA. Popul Health Manag. 2009; 12(4):205-8.
You JJ, Levinson W, Laupacis A. Healthc Policy. 2009; 5(1):54-65.
Saposnik G, Kapral MK, Coutts SB, Fang J, Demchuk AM, Hill MD; Investigators of the Registry of the Canadian Stroke Network (RCSN) for the Stroke Outcome Research Canada (SORCan) Working Group. Stroke. 2009; 40(10):3321-7. Epub 2009 Jul 30.
Gladstone DJ, Oh J, Fang J, Lindsay P, Tu JV, Silver FL, Kapral MK. Stroke. 2009; 40(8):2776-82. Epub 2009 Jun 18.
Burneo JG, Fang J, Saposnik G; Investigators of the Registry of the Canadian Stroke Network. Eur J Neurol. 2010; 17(1):52-8. Epub 2009 Jul 21.
Lee DS, Chiu M, Manuel DG, Tu K, Wang X, Austin PC, Mattern MY, Mitiku TF, Svenson LW, Putnam W, Flanagan WM, Tu JV; Canadian Cardiovascular Outcomes Research Team,CMAJ. 2009; 181(3-4):e55-66. Epub 2009 Jul 20.